Chen Xiaohong, Zhang Jianfeng, Yu Yan, Wang Haoran, Ma Genshan, Wang Di, Cao Hanzhong, Yang Jianping
The Frist Affiliated Hospital of Soochow University, Suzhou, China.
Nantong Tumor Hospital, Tumor Hospital Affiliated to Nantong University, Nantong, China.
Front Bioeng Biotechnol. 2022 Jul 11;10:925047. doi: 10.3389/fbioe.2022.925047. eCollection 2022.
Safe and non-invasive on-demand relief is a crucial and effective treatment for postoperative pain because it considers variable timing and intensity of anesthetics. Ultrasound modulation is a promising technique for this treatment because it allows convenient timed and non-invasive controlled drug release. Here, we created an ultrasound-triggered lidocaine (Lido) release platform using an amino acid hydrogel functioning as three-dimensional (3D) scaffold material (Lido-PPIX@ER hydrogel). It allows control of the timing, intensity and duration of lidocaine (Lido) to relieve postoperative pain. The hydrogel releases Lido due to the elevated reactive oxygen species (ROS) levels generated by PPIX under ultrasound triggering. The Lido-PPIX@ER hydrogel under individualized ultrasound triggering released lidocaine and provided effective analgesia for more than 72 h. The withdrawal threshold was higher than that in the control group at all time points measured. The hydrogel showed repeatable and adjustable ultrasound-triggered nerve blocks , the duration of which depended on the extent and intensity of insonation. On histopathology, no systemic effect or tissue reaction was observed in the ultrasound-triggered Lido-PPIX@ER hydrogel-treated group. The Lido-PPIX@ER hydrogel with individualized (highly variable) ultrasound triggering is a convenient and effective method that offers timed and spatiotemporally controlled Lido release to manage postoperative pain. This article presents the delivery system for a new effective strategy to reduce pain, remotely control pain, and offer timed and spatiotemporally controlled release of Lido to manage postoperative pain.
安全且无创的按需缓解是术后疼痛的关键有效治疗方法,因为它考虑了麻醉剂的可变时间和强度。超声调制是一种很有前景的治疗技术,因为它允许方便地定时和无创控制药物释放。在此,我们创建了一种超声触发的利多卡因(Lido)释放平台,使用氨基酸水凝胶作为三维(3D)支架材料(Lido-PPIX@ER水凝胶)。它可以控制利多卡因(Lido)的释放时间、强度和持续时间,以缓解术后疼痛。在超声触发下,水凝胶由于PPIX产生的活性氧(ROS)水平升高而释放Lido。个体化超声触发下的Lido-PPIX@ER水凝胶释放利多卡因,并提供超过72小时的有效镇痛。在所有测量时间点,撤药阈值均高于对照组。该水凝胶显示出可重复和可调节的超声触发神经阻滞,其持续时间取决于超声照射的范围和强度。组织病理学检查显示,超声触发的Lido-PPIX@ER水凝胶治疗组未观察到全身效应或组织反应。具有个体化(高度可变)超声触发的Lido-PPIX@ER水凝胶是一种方便有效的方法,可提供定时和时空控制的Lido释放以管理术后疼痛。本文介绍了一种新的有效策略的给药系统,该策略可减轻疼痛、远程控制疼痛,并提供定时和时空控制的Lido释放以管理术后疼痛。